A Protracted Course of COVID19 Infection in a Metastatic Breast Cancer Patient During CDK4/6 Inhibitor Therapy

We describe the first case report of a patient with COVID19 infection and metastatic breast cancer, while on systemic therapy with a CDK4/6 inhibitor. The patient had unique disease course, characterized with delayed symptomatology. The case highlights novel findings and stress careful and extended...

Descripción completa

Detalles Bibliográficos
Autores principales: Grinshpun, Albert, Merlet, Irit, Fruchtman, Hila, Nachman, Dean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295974/
https://www.ncbi.nlm.nih.gov/pubmed/32582559
http://dx.doi.org/10.3389/fonc.2020.01085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295974/
https://www.ncbi.nlm.nih.gov/pubmed/32582559
http://dx.doi.org/10.3389/fonc.2020.01085

Ejemplares similares